J Dentofacial Anom Orthod
Volume 20, Number 1, 2017
|Number of page(s)||11|
|Published online||23 April 2018|
Orthodontic strategies in pediatric oncology
Microbiology team, EA1254, University of Rennes, CHU Rennes, 2 avenue du Professeur Léon-Bernard, 35000 Rennes, France
2 Department of Pediatric hematology-oncology, CHU Hospital South, CHU Rennes, 16 boulevard de Bulgarie, 35200 Rennes, France
Address for correspondence: Martine Bonnaure-Mallet, Université de Rennes 1 – 2 avenue du Professeur Léon-Bernard – 35000 Rennes. E-mail: firstname.lastname@example.org
Accepted: 1 September 2016
Cancer in children is not uncommon and can occur at any age. After summarizing the pediatric cancer epidemiology, dentofacial orthopedics and orthodontics during anticancer treatments will be discussed. Orthodontic management in children with cancer differ depending on the type and time of the anticancer therapy: before, during and after chemo- or radiotherapy. The pathophysiological, psychological, administrative and technical concerns are described for every situation. Finally, we suggest some recommendations, according to the current knowledge and our own dentist experience in the pediatric oncology department of Rennes.
Key words: Hematologic neoplasms / cancer / anticancer agents / mucositis / orthodontics / child / adolescent
© The authors
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.